Concepts (178)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Amyloidosis | 2 | 2022 | 788 | 1.060 |
Why?
|
| Prothrombin Time | 1 | 2020 | 124 | 0.800 |
Why?
|
| International Normalized Ratio | 1 | 2020 | 364 | 0.710 |
Why?
|
| Drug Therapy, Computer-Assisted | 1 | 2020 | 207 | 0.710 |
Why?
|
| Vitamin K | 1 | 2020 | 283 | 0.680 |
Why?
|
| Hematocrit | 1 | 2019 | 636 | 0.660 |
Why?
|
| Erythropoiesis | 1 | 2019 | 708 | 0.540 |
Why?
|
| Receptors, Thrombin | 1 | 2015 | 139 | 0.530 |
Why?
|
| Myocardial Revascularization | 1 | 2019 | 839 | 0.530 |
Why?
|
| Blood Coagulation | 1 | 2020 | 1114 | 0.520 |
Why?
|
| Drug Monitoring | 1 | 2020 | 936 | 0.510 |
Why?
|
| Artificial Intelligence | 3 | 2022 | 1661 | 0.510 |
Why?
|
| Cardiomyopathy, Hypertrophic | 1 | 2022 | 1195 | 0.500 |
Why?
|
| Echocardiography | 4 | 2022 | 5139 | 0.490 |
Why?
|
| Diagnosis, Computer-Assisted | 1 | 2019 | 709 | 0.490 |
Why?
|
| Atrial Fibrillation | 2 | 2022 | 4454 | 0.490 |
Why?
|
| Lactones | 1 | 2015 | 340 | 0.450 |
Why?
|
| Electrocardiography | 3 | 2022 | 6386 | 0.450 |
Why?
|
| Chest Pain | 1 | 2019 | 1100 | 0.420 |
Why?
|
| Myocardial Infarction | 4 | 2021 | 11323 | 0.400 |
Why?
|
| Anticoagulants | 2 | 2022 | 4293 | 0.350 |
Why?
|
| Secondary Prevention | 1 | 2015 | 1505 | 0.340 |
Why?
|
| Myocytes, Cardiac | 4 | 2021 | 1641 | 0.340 |
Why?
|
| Membrane Lipids | 2 | 2019 | 253 | 0.330 |
Why?
|
| Osteopontin | 2 | 2020 | 349 | 0.330 |
Why?
|
| Stroke | 2 | 2020 | 9256 | 0.290 |
Why?
|
| Heart | 1 | 2019 | 4315 | 0.290 |
Why?
|
| Acute Coronary Syndrome | 1 | 2019 | 2232 | 0.280 |
Why?
|
| MicroRNAs | 1 | 2021 | 3655 | 0.270 |
Why?
|
| Phospholipids | 2 | 2019 | 813 | 0.270 |
Why?
|
| Kidney | 1 | 2019 | 6888 | 0.250 |
Why?
|
| Hypertension | 1 | 2022 | 8161 | 0.230 |
Why?
|
| Pyridines | 1 | 2015 | 2862 | 0.230 |
Why?
|
| Fatty Acids, Monounsaturated | 2 | 2019 | 187 | 0.210 |
Why?
|
| Thrombosis | 1 | 2015 | 2840 | 0.210 |
Why?
|
| Transmembrane Activator and CAML Interactor Protein | 1 | 2021 | 58 | 0.210 |
Why?
|
| Ubiquitin-Protein Ligases | 2 | 2021 | 1860 | 0.200 |
Why?
|
| Macrophages | 3 | 2021 | 5784 | 0.200 |
Why?
|
| Cell Hypoxia | 2 | 2020 | 686 | 0.190 |
Why?
|
| Diastole | 2 | 2019 | 836 | 0.190 |
Why?
|
| Hematology | 1 | 2022 | 195 | 0.190 |
Why?
|
| Adrenal Cortex | 1 | 2020 | 144 | 0.190 |
Why?
|
| Palmitic Acid | 1 | 2020 | 159 | 0.190 |
Why?
|
| Triazines | 1 | 2021 | 308 | 0.180 |
Why?
|
| Diuresis | 1 | 2019 | 121 | 0.180 |
Why?
|
| Membranes | 1 | 2018 | 174 | 0.180 |
Why?
|
| Diabetes Mellitus, Type 2 | 2 | 2019 | 10857 | 0.180 |
Why?
|
| Glutathione | 1 | 2021 | 621 | 0.180 |
Why?
|
| Ventricular Dysfunction | 1 | 2019 | 141 | 0.170 |
Why?
|
| Cardiomyopathies | 2 | 2021 | 1819 | 0.170 |
Why?
|
| Decision Making, Computer-Assisted | 1 | 2019 | 162 | 0.170 |
Why?
|
| Diabetic Cardiomyopathies | 1 | 2019 | 93 | 0.170 |
Why?
|
| STAT3 Transcription Factor | 2 | 2020 | 895 | 0.170 |
Why?
|
| Pacemaker, Artificial | 1 | 2022 | 762 | 0.160 |
Why?
|
| Heart Failure | 4 | 2022 | 10040 | 0.160 |
Why?
|
| Sirtuin 1 | 1 | 2019 | 306 | 0.160 |
Why?
|
| Receptors, Glucocorticoid | 1 | 2019 | 308 | 0.160 |
Why?
|
| Diabetes Mellitus | 1 | 2015 | 5348 | 0.160 |
Why?
|
| Galectin 3 | 1 | 2018 | 217 | 0.160 |
Why?
|
| Kidney Tubules, Proximal | 1 | 2019 | 452 | 0.150 |
Why?
|
| Sodium-Potassium-Exchanging ATPase | 1 | 2019 | 504 | 0.150 |
Why?
|
| DNA | 2 | 2021 | 7172 | 0.150 |
Why?
|
| Sympathetic Nervous System | 1 | 2019 | 533 | 0.150 |
Why?
|
| Cardiomegaly | 1 | 2019 | 653 | 0.140 |
Why?
|
| Atrioventricular Block | 1 | 2016 | 110 | 0.140 |
Why?
|
| Aldosterone | 1 | 2020 | 799 | 0.140 |
Why?
|
| Predictive Value of Tests | 3 | 2022 | 15252 | 0.140 |
Why?
|
| Mitochondrial Proteins | 1 | 2021 | 990 | 0.140 |
Why?
|
| Adenosine Triphosphatases | 1 | 2019 | 894 | 0.130 |
Why?
|
| Dystonic Disorders | 1 | 2018 | 326 | 0.130 |
Why?
|
| Doxorubicin | 1 | 2021 | 2235 | 0.130 |
Why?
|
| Erythropoietin | 1 | 2019 | 731 | 0.130 |
Why?
|
| Leukemia | 1 | 2022 | 1496 | 0.130 |
Why?
|
| Heart Valve Prosthesis | 1 | 2022 | 1492 | 0.120 |
Why?
|
| Warfarin | 1 | 2022 | 1440 | 0.120 |
Why?
|
| Heart Septal Defects, Atrial | 1 | 2016 | 491 | 0.120 |
Why?
|
| Fatty Acids, Omega-3 | 1 | 2022 | 1267 | 0.120 |
Why?
|
| Hemoglobins | 1 | 2019 | 1490 | 0.120 |
Why?
|
| Interleukin-10 | 1 | 2018 | 1213 | 0.120 |
Why?
|
| MAP Kinase Signaling System | 1 | 2020 | 1588 | 0.120 |
Why?
|
| Thalamus | 1 | 2018 | 998 | 0.110 |
Why?
|
| Administration, Oral | 1 | 2020 | 3944 | 0.110 |
Why?
|
| Adenosine Triphosphate | 1 | 2019 | 2203 | 0.110 |
Why?
|
| Diabetic Nephropathies | 1 | 2019 | 1042 | 0.110 |
Why?
|
| Hypertension, Pulmonary | 1 | 2022 | 1489 | 0.110 |
Why?
|
| Fatty Acids | 1 | 2019 | 1741 | 0.100 |
Why?
|
| Monocytes | 1 | 2021 | 2660 | 0.100 |
Why?
|
| Protein Unfolding | 2 | 2021 | 60 | 0.100 |
Why?
|
| Aortic Valve Stenosis | 1 | 2022 | 1832 | 0.100 |
Why?
|
| Feasibility Studies | 1 | 2019 | 4883 | 0.090 |
Why?
|
| Hemorrhage | 1 | 2020 | 3235 | 0.090 |
Why?
|
| Stroke Volume | 1 | 2021 | 4522 | 0.090 |
Why?
|
| Humans | 17 | 2022 | 708843 | 0.090 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2021 | 17218 | 0.080 |
Why?
|
| Mice | 8 | 2022 | 80876 | 0.080 |
Why?
|
| Time Factors | 2 | 2020 | 41038 | 0.080 |
Why?
|
| Neurosurgical Procedures | 1 | 2018 | 2020 | 0.080 |
Why?
|
| Glucose | 1 | 2019 | 4261 | 0.080 |
Why?
|
| Patient Selection | 1 | 2019 | 4306 | 0.070 |
Why?
|
| Animals | 11 | 2022 | 170486 | 0.070 |
Why?
|
| Membrane Proteins | 2 | 2021 | 8072 | 0.070 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2019 | 1938 | 0.070 |
Why?
|
| Reproducibility of Results | 2 | 2022 | 19423 | 0.070 |
Why?
|
| Mutation | 2 | 2021 | 29262 | 0.070 |
Why?
|
| RNA, Messenger | 1 | 2021 | 13314 | 0.070 |
Why?
|
| Cell Death | 2 | 2021 | 1738 | 0.070 |
Why?
|
| Treatment Outcome | 3 | 2022 | 61932 | 0.070 |
Why?
|
| Databases, Factual | 1 | 2020 | 7763 | 0.070 |
Why?
|
| Transcription, Genetic | 1 | 2019 | 7965 | 0.070 |
Why?
|
| Registries | 1 | 2020 | 7989 | 0.060 |
Why?
|
| Gene Expression Profiling | 1 | 2021 | 9556 | 0.060 |
Why?
|
| Mice, Knockout | 4 | 2021 | 15274 | 0.060 |
Why?
|
| Cells, Cultured | 4 | 2021 | 20170 | 0.060 |
Why?
|
| Sensitivity and Specificity | 1 | 2019 | 14836 | 0.060 |
Why?
|
| Diagnosis, Differential | 1 | 2019 | 13274 | 0.060 |
Why?
|
| gamma-Glutamylcyclotransferase | 1 | 2021 | 8 | 0.060 |
Why?
|
| Disease Progression | 1 | 2019 | 13298 | 0.060 |
Why?
|
| Risk Assessment | 2 | 2022 | 23284 | 0.060 |
Why?
|
| Epoxy Compounds | 1 | 2022 | 148 | 0.050 |
Why?
|
| Mice, Inbred C57BL | 4 | 2021 | 22989 | 0.050 |
Why?
|
| Rats, Inbred Dahl | 1 | 2020 | 49 | 0.050 |
Why?
|
| Sterol Esterase | 1 | 2020 | 37 | 0.050 |
Why?
|
| RING Finger Domains | 1 | 2019 | 9 | 0.050 |
Why?
|
| Receptors, Adrenergic, beta-3 | 1 | 2020 | 64 | 0.050 |
Why?
|
| Gene Expression Regulation | 1 | 2019 | 12447 | 0.050 |
Why?
|
| Risk Factors | 3 | 2022 | 69553 | 0.050 |
Why?
|
| Zona Glomerulosa | 1 | 2020 | 88 | 0.050 |
Why?
|
| Emergency Service, Hospital | 1 | 2019 | 7428 | 0.050 |
Why?
|
| Catecholamines | 1 | 2020 | 391 | 0.040 |
Why?
|
| Male | 8 | 2021 | 349524 | 0.040 |
Why?
|
| Mannose-Binding Lectins | 1 | 2018 | 108 | 0.040 |
Why?
|
| Cardiac Pacing, Artificial | 1 | 2022 | 847 | 0.040 |
Why?
|
| Prognosis | 1 | 2019 | 28919 | 0.040 |
Why?
|
| Phosphorylation | 2 | 2020 | 8720 | 0.040 |
Why?
|
| Cardiovascular Diseases | 1 | 2022 | 14075 | 0.040 |
Why?
|
| Unfolded Protein Response | 1 | 2018 | 244 | 0.040 |
Why?
|
| Disease Models, Animal | 3 | 2020 | 18375 | 0.040 |
Why?
|
| Signal Transduction | 1 | 2020 | 23950 | 0.040 |
Why?
|
| Prospective Studies | 1 | 2020 | 50597 | 0.040 |
Why?
|
| Septal Occluder Device | 1 | 2016 | 122 | 0.040 |
Why?
|
| Female | 6 | 2021 | 375205 | 0.030 |
Why?
|
| Lectins, C-Type | 1 | 2018 | 617 | 0.030 |
Why?
|
| Aged, 80 and over | 1 | 2020 | 58184 | 0.030 |
Why?
|
| Mast Cells | 1 | 2022 | 1601 | 0.030 |
Why?
|
| Animals, Newborn | 1 | 2020 | 2877 | 0.030 |
Why?
|
| Rats | 2 | 2021 | 25094 | 0.030 |
Why?
|
| Endoplasmic Reticulum | 1 | 2020 | 1200 | 0.030 |
Why?
|
| Pedigree | 1 | 2021 | 4724 | 0.030 |
Why?
|
| Phagocytosis | 1 | 2018 | 1594 | 0.030 |
Why?
|
| Aortic Valve | 1 | 2022 | 1817 | 0.030 |
Why?
|
| Disease Susceptibility | 1 | 2019 | 1778 | 0.030 |
Why?
|
| Transcriptional Activation | 1 | 2018 | 1849 | 0.030 |
Why?
|
| HEK293 Cells | 1 | 2021 | 4310 | 0.030 |
Why?
|
| Ventricular Remodeling | 1 | 2019 | 1280 | 0.030 |
Why?
|
| Down-Regulation | 1 | 2018 | 3093 | 0.030 |
Why?
|
| Aged | 2 | 2020 | 161488 | 0.030 |
Why?
|
| Cholesterol | 1 | 2020 | 2866 | 0.030 |
Why?
|
| Bone Marrow Cells | 1 | 2018 | 2596 | 0.020 |
Why?
|
| Triglycerides | 1 | 2018 | 2564 | 0.020 |
Why?
|
| DNA Mutational Analysis | 1 | 2019 | 4317 | 0.020 |
Why?
|
| Lipid Metabolism | 1 | 2019 | 1999 | 0.020 |
Why?
|
| Oxidative Stress | 1 | 2021 | 3156 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 2020 | 6127 | 0.020 |
Why?
|
| RNA Interference | 1 | 2018 | 3026 | 0.020 |
Why?
|
| RNA, Small Interfering | 1 | 2018 | 3645 | 0.020 |
Why?
|
| Computer Simulation | 1 | 2022 | 6048 | 0.020 |
Why?
|
| Receptors, Cell Surface | 1 | 2018 | 2913 | 0.020 |
Why?
|
| Myocardium | 1 | 2018 | 4969 | 0.020 |
Why?
|
| Cell Line | 1 | 2020 | 16657 | 0.020 |
Why?
|
| Blood Pressure | 1 | 2019 | 8528 | 0.010 |
Why?
|
| Longitudinal Studies | 1 | 2018 | 13536 | 0.010 |
Why?
|
| Retrospective Studies | 2 | 2022 | 71483 | 0.010 |
Why?
|
| Phenotype | 1 | 2019 | 16306 | 0.010 |
Why?
|
| Adult | 3 | 2021 | 211041 | 0.010 |
Why?
|
| Middle Aged | 3 | 2019 | 213752 | 0.010 |
Why?
|
| Child | 1 | 2022 | 73636 | 0.010 |
Why?
|
| Young Adult | 1 | 2018 | 55940 | 0.010 |
Why?
|
| Adolescent | 1 | 2018 | 84718 | 0.010 |
Why?
|
Concepts
(178)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(8)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_